Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tjalling Bosse

Showing results (101-110 of 167) with videos related to

Pageof 17
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 7, 2024
Clinical and Molecular Characteristics of High-Risk, Recurrent, or Metastatic Endometrial Cancer That Is Human Epidermal Growth Factor Receptor 2-LowDione van Dijk, Lisa Vermij, Alicia León-Castillo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 8, 2019
Germline <i>BRCA</i>-Associated Endometrial Carcinoma Is a Distinct Clinicopathologic EntityMarthe M de Jonge, Lauren L Ritterhouse, Cornelis D de Kroon, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 9, 2019
Integrated Molecular Analysis of Undifferentiated Uterine Sarcomas Reveals Clinically Relevant Molecular SubtypesAmrei Binzer-Panchal, Elin Hardell, Björn Viklund, et al.
The American Journal of Surgical Pathology|March 6, 2018
Molecular Classification of Grade 3 Endometrioid Endometrial Cancers Identifies Distinct Prognostic SubgroupsTjalling Bosse, Remi A Nout, Jessica N McAlpine, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|November 22, 2024
Retinoblastoma Protein Loss in p53 Abnormal Endometrial Carcinoma: Histologic and Clinicopathological CorrelatesEzgi Dicle Serbes, Nanda Horeweg, Carlos Parra-Herran, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|June 30, 2018
Refinement of high-risk endometrial cancer classification using DNA damage response biomarkers: a TransPORTEC initiativeAurélie Auguste, Catherine Genestie, Marco De Bruyn, et al.
International Journal of Radiation Oncology, Biology, Physics|July 27, 2024
Biomarker Expression and Clinical Outcomes in International Study of Chemoradiation and Magnetic Resonance Imaging-Based Image-Guided Brachytherapy for Locally Advanced Cervical Cancer: BIOEMBRACESupriya Chopra, Tjalling Bosse, Nanda Horeweg, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|June 23, 2024
APOLLO: neo-adjuvant pembrolizumab for primary vulvar squamous cell carcinoma-a multicenter, single-arm, phase II, clinical proof-of-concept studyM I E van Poelgeest, Kim E Kortekaas, Helena C van Doorn, et al.
Journal of the National Cancer Institute|December 16, 2014
Prognostic significance of POLE proofreading mutations in endometrial cancerDavid N Church, Ellen Stelloo, Remi A Nout, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 17, 2016
A Novel Tumor-Specific Agent for Intraoperative Near-Infrared Fluorescence Imaging: A Translational Study in Healthy Volunteers and Patients with Ovarian CancerCharlotte E S Hoogstins, Quirijn R J G Tummers, Katja N Gaarenstroom, et al.
Pageof 17

Showing results (101-110 of 167) with videos related to

Sort By:
Pageof 17
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 7, 2024
Clinical and Molecular Characteristics of High-Risk, Recurrent, or Metastatic Endometrial Cancer That Is Human Epidermal Growth Factor Receptor 2-LowDione van Dijk, Lisa Vermij, Alicia León-Castillo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 8, 2019
Germline <i>BRCA</i>-Associated Endometrial Carcinoma Is a Distinct Clinicopathologic EntityMarthe M de Jonge, Lauren L Ritterhouse, Cornelis D de Kroon, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 9, 2019
Integrated Molecular Analysis of Undifferentiated Uterine Sarcomas Reveals Clinically Relevant Molecular SubtypesAmrei Binzer-Panchal, Elin Hardell, Björn Viklund, et al.
The American Journal of Surgical Pathology|March 6, 2018
Molecular Classification of Grade 3 Endometrioid Endometrial Cancers Identifies Distinct Prognostic SubgroupsTjalling Bosse, Remi A Nout, Jessica N McAlpine, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|November 22, 2024
Retinoblastoma Protein Loss in p53 Abnormal Endometrial Carcinoma: Histologic and Clinicopathological CorrelatesEzgi Dicle Serbes, Nanda Horeweg, Carlos Parra-Herran, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|June 30, 2018
Refinement of high-risk endometrial cancer classification using DNA damage response biomarkers: a TransPORTEC initiativeAurélie Auguste, Catherine Genestie, Marco De Bruyn, et al.
International Journal of Radiation Oncology, Biology, Physics|July 27, 2024
Biomarker Expression and Clinical Outcomes in International Study of Chemoradiation and Magnetic Resonance Imaging-Based Image-Guided Brachytherapy for Locally Advanced Cervical Cancer: BIOEMBRACESupriya Chopra, Tjalling Bosse, Nanda Horeweg, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|June 23, 2024
APOLLO: neo-adjuvant pembrolizumab for primary vulvar squamous cell carcinoma-a multicenter, single-arm, phase II, clinical proof-of-concept studyM I E van Poelgeest, Kim E Kortekaas, Helena C van Doorn, et al.
Journal of the National Cancer Institute|December 16, 2014
Prognostic significance of POLE proofreading mutations in endometrial cancerDavid N Church, Ellen Stelloo, Remi A Nout, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 17, 2016
A Novel Tumor-Specific Agent for Intraoperative Near-Infrared Fluorescence Imaging: A Translational Study in Healthy Volunteers and Patients with Ovarian CancerCharlotte E S Hoogstins, Quirijn R J G Tummers, Katja N Gaarenstroom, et al.
Pageof 17